Дифференциальная экспрессия онкозначимых генов при светлоклеточном раке почки
Диссертация
Представленная работа посвящена количественной оценке содержания мРНК генов, расположенных на коротком плече хромосомы 3, которые могут проявлять себя как TSG в эпителиальных опухоляхVHL, RBSP3, SEMA3B, SEMA3 °F, HYALl, HYAL2, NPRL2, генов кандидатов в TSG — ITGA9, VILL, СНЫ, гена RB1, продукт которого является основной мишенью RBSP3, а также генов, кодирующих субъединицы ферритина — FTL и FTH… Читать ещё >
Список литературы
- Блинов H.H. TNM: Классификация злокачественных опухолей. 2003. 6-е изд. СПб.: Эскулап. С. 192−196.
- Брага Э.А., Киселев Л. Л., Забаровский Е. Р. От идентификации геномного полиморфизма к диагностическим и прогностическим маркерам эпителиальных опухолей. Молекулярная биология. 2004. 38. С. 145−154.
- Киселев Л.Л., Сенченко В. Н., Опарина Н. Ю., Брага Э. А., Забаровский Е. Р. Гены-супрессоры-опухолевого роста, локализованные на коротком плече хромосомы 3 человека. Молекулярная медицина 2005. 3. С. 17−28.
- Коваленко H.A., Головченко К. В., Лесничук С. А. и др. Определение активности теломеразы в новообразованиях почки и простаты. Вопр. биол., мед. и фармац. химии. 2003. 1. С. 21—25.
- Копнин Б.П. Мишени действия онкогенов и опухолевых супрессоров: ключ к пониманию базовых механизмов канцерогенеза. Биохимия. 2000. 65(1). С. 5−33.
- Лукьянов К.А., Гурская Н. Г., Богданова Е. А., Лукьянов С. А. Селективная супрессия полимеразной цепной реакции. Биоорганическая химия. 1999. (25)3. С. 163−170.
- Татосян А.Г. Онкогены. Сборник обзорных статей «Канцерогенез». 2000. под ред. Д. Г. Заридзе, М: Научн. Мир, стр. 57−74.
- Чумаков П.М. Функция гена р53: выбор между жизнью и смертью. Биохимия. 2000. 65(1). С. 34−47.
- RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer. Mol Biol (Mosk). 2008. 42(6). P. 965−976.
- Angeloni D. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct Genomic Proteomic. 2007. 6(1). P. 19−39.
- Albelda S.M. Endothelial and epithelial cell adhesion molecules. Am J Respir Cell Mol Biol. 1991. 3. P. 195−203.
- H.Bernard P. S., Wittwer C.T. Real-time PCR technology for cancer diagnostics. Clin Chem. 2002. 48(8). P. l 178−1185.
- Bertrand P., Courel M.N., Maingonnat C., Jardin F., Tilly H., Bastard C. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness. Int J Cancer. 2005. 113(2). P. 207−212.
- Brambilla E., Constantin B., Drabkin H., Roche J. Semaphorin SEMA3 °F localization in malignant human lung and cell lines: Asuggested role in cell adhesion and cell migration. Am J Pathol. 2000. 156(3). 939−950.
- Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000. 25(2). P. 169−193.
- Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problms. J Mol Endocrinol. 2002. 29(1). P. 23−39.
- Cowey C.L., Hutson T.E. Molecularly targeted agents for renal cell carcinoma: the next generation. Clin Adv Hematol Oncol. 2010. 8(5). P. 357−64.
- Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001. 20(8). P. 499−508.
- Dacic S. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis. Expert Rev. Mol. Diagn. 2007. 7(1). P. 77−86.
- Dheda K., Huggett J.F., Bustin S.A., Johnson M.A., Rook G., Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004. 37(1). P. 112−114, 116, 118−119.
- Duan D.R., Pause A., Burgess W.H., Aso T., Chen D.Y., Garrett K.P., Conaway R.C., Conaway J.W., Linehan W.M., Klausner R.D. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science. 1995. 269(5229). P. 1402−1406.
- Essen A., Ozen H., Ayhan A., Ergen A., Tasar C., Remzi F. Serum ferritin: a tumor marker for renal cell carcinoma. J. Urol. 1991. 145(6). P. 1134−1137.
- Eymin B., Gazzeri S., Brambilla C., Brambilla E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma./ Oncogene. 2001. 20(14). P. 1678−1687.
- Eymin B., Gazzeri S., Brambilla C., Brambilla E. Mdm2 overexpression and pl4(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Oncogene. 2002. 21(17). P. 2750−2761.
- Fear N.T., Vincent T.J., King J.C., MacCarthy A., Bunch K.J., Murphy M.F. Wilms tumour and paternal occupation: an analysis of data from the National Registry of Childhood Tumours. Pediatr Blood Cancer. 2009. 53(1). P. 28−32.
- Franzmann E. J, Schroeder G.L., Goodwin W.J., Weed D.T., Fisher P. Lokeshwar V.B. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer. 2003. 106(3). P. 438−445.
- Fujisawa H, Kitsukawa T. Receptors for collapsin/semaphorins. Curr Opin Neurobiol. 1998. 8(5). 587−592.
- Gao W., Keohavong P. Analysis of K-RAS and P53 mutations in sputum samples. Methods Mol Biol. 2005. 291. P. 217−233.
- GeneCards database, http://bioinformatics.weizmann. ac. il/cards/
- Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 1996. 6(10). P. 995−1001.
- Grail A, Hancock B. W, Harrison P. 1992. Serum ferritin in normal individuals and in patients with malignant lymphoma and chronic renal failure measured with seven different commercial immunoassay techniques. J Clin Pathol. 35, 1204—1212.
- Groulx I., Lee S. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol. 2002. 22(15). P. 5319−5336.
- Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000. 100(1). P. 57−70.
- Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N Engl J Med. 2002. 347(20). P. 1593−1603.
- Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 1996. 6(10). P. 986−994.
- Hesson L.B., Cooper W.N., Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene. 2007. 26. P. 7283−7301.
- Jacobson A., Rahmanian M., Rubin K., Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer. 2002. 102(3). P. 212−219.
- Ji L., Minna J.D., Roth J.A., 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol. 2005. 1(1). P. 79−92.
- Kibel A., Iliopoulos O., DeCaprio J.A., Kaelin W.G. Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science. 1995. 269(5229). P.1444−1446.
- Klatte T., Pantuck A.J. Molecular biology of renal cortical tumors. Urol Clin North Am. 2008. 35(4). P. 573−580.
- Knudson A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985. 45. P. 1437−1443.
- Ko J.L., Cheng Y.W., Chang S.L., Su J.M., Chen C.Y., Lee H. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Int J Cancer. 2000. 89(3). P. 265−270.
- Koorts A.M., Viljoen M. Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. Arch Physiol Biochem. 2007 (1). 113(2). P. 55−64.
- Koorts A.M., Viljoen M. Ferritin and ferritin isoforms I: Structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem. 2007 (2). 113(1). P. 30−54.
- Kovar J.L., Johnson M.A., Volcheck W.M., Chen J., Simpson M.A. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol. 2006. 169(4). P. 1415−1426.
- Kuroki, T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Williams N.N., Kaiser L.R., Croce C.M. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res. 2003. 63(12). P.3352−3355.
- Lee S., Chen D.Y., Humphrey J.S., Gnarra J.R., Linehan W.M., Klausner R.D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA. 1996. 93(5). P. 1770−1775.
- Lepperdinger G., Strobl B., Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem. 1998. 273(35). P. 22 466−22 470
- Li J., Wang F., Haraldson K., Protopopov A., Duh F.M., Geil L., Kuzmin I., Minna J.D., Stanbridge E., Braga E., Kashuba V.I., Klein
- G., Lerman M.I., Zabarovsky E.R. Functional characterization of the candidate tumor suppressor gene NPRL2 located in 3p21.3C. Cancer Res. 2004. 64. P. 6438−6443.
- Li R., Todd N.W., Qiu Q., Fan T., Zhao R.Y., Rodgers W.H., Fang
- H.B., Katz R.L., Stass S.A., Jiang F. Genetic deletions in sputum asdiagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res. 2007. 13(2). P. 482−487.
- Liu D.W., Chen S.T., Liu H.P. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J. 2005. 26(6). P. 1002−1008.
- Lokeshwar V.B., Cerwinka W.H., Lokeshwar B.L. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res. 2005 (a). 65(6). P. 2243−2250.
- Lokeshwar V.B., Cerwinka W.H., Isoyama T., Lokeshwar B.L. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res. 2005 (b). 65(17). P. 7782−7789.
- Madan A.K., Yu K., Dhurandhar N., Cullinane C., Pang Y., Beech D.J. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol Rep. 1999. 6(3). P. 607−609.
- Mertz J.R., Theil E.C. Subunit dimers in sheep spleen apoferritin. The effect on iron storage. J Biol Chem. 1983. 258(19). P. 11 719−11 726.
- Milman N, Pedersen L. 2002. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncology reports. 9, 193—198.
- Miyata Y., Koga S., Nishikido M., Hayashi T., Kanetake H. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int. 2001. 88(9), P. 974−977.
- Palmer E.L., Ruegg C., Ferrando R., Pytela R., Sheppard D. Sequence and tissue distribution of the integrin alpha-9 subunit, a novel partner of beta-1 that is widely distributed in epithelia and muscle. J. Cell Biol. 1993. 123. P. 1289−1297.
- Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003. 3(4). P. 34 761.
- Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004. 313. P. 856−862.
- Richards F, M" Schofield P, N" Fleming S" Maher E, R. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet. 1996. 5(5). P.639−644.
- Ronai Z., Yabubovskaya M.S., Zhang E., Belitsky G.A. K-ras mutation in sputum of patients with or without lung cancer. J Cell Biochem Suppl. 1996. 25. P. 172−176.
- Sammarco M.C., Ditch S., Banerjee A., Grabczyk E. Ferritin L and H subunits are differentially regulated on a post-transcriptional level. J Biol Chem. 2008. 283(8). 4578−4587.
- Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000. 103(2). P. 211−225.
- Shu J., Jelinek J., Chang H., Shen L., Qin T., Chung W., Oki Y., Issa J.P. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res. 2006. 66(10). P. 5077−5084.
- Simpson M.A. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol. 2006. 169(1). P. 247−257.
- Takagi Y., Pause A., Conaway R.C., Conaway J.W. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein. J Biol Chem. 1997. 272(43). P. 27 444−27 449.
- Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer. 2004. 4. P. 528−539.
- Tse C., Xiang R.H., Bracht T., Naylor S.L. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 2002. 62(2). P. 542−546.
- Virmani AK., Gazdar A.F. Tumor suppressor genes in Lung cancer. Methods Mol. Biol. 2003. 222. P. 97−115.
- Wang J., Xie L.Y., Allan S., Beach D., Hannon G.J. Myc activates telomerase. Genes Dev. 1998. 12(12). P. 1769−1774.
- Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 1995. 81. P. 323−330.
- Wistuba I.I., Lam S., Behrens C., Virmani A.K., Fong K.M., LeRiche J., Samet J.M., Srivastava S., Minna J.D., Gazdar A.F. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997. 89(18). P. 1366−1373.
- Wong M.L., Medrano J.F. Real-time PCR for mRNA quantification. BioTechniques. 2005. 39. P. 1−11.
- Xiang R., Davalos A.R., Hensel C.H., Zhou X.J., Tse C., Naylor S.L. Semaphorin 3 °F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 2002. 62(9). P. 2637−2643.
- Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2001. 2. P. 127- 137.
- Ye Y., Vasavada S., Kuzmin I., Stackhouse T., Zbar B., Williams B.R. Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent. Int J Cancer. 1998. 78(1). P. 62−69.
- Yeo M., Lin P. S., Dahmus M.E., Gill G.N. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J Biol Chem. 2003. 278(28) P. 26 078−26 085
- Zabarovsky E.R., Lerman M.I., Minna J.D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002. 21(45). P.6915−6935.
- Zabarovsky et al. Lung cancer principles and practice, third edition, 2005. P. 118−133.
- Zhang L., Underhill C.B., Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995. 55(2). P. 428−433.1. БЛАГОДАРНОСТИ